Viatris Inc (VTRS) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.026x

Based on the latest financial reports, Viatris Inc (VTRS) has a cash flow conversion efficiency ratio of 0.026x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($388.30 Million) by net assets ($14.66 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See VTRS defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Viatris Inc - Cash Flow Conversion Efficiency Trend (1985–2025)

This chart illustrates how Viatris Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Viatris Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Viatris Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Essity AB (publ)
ST:ESSITY-B
0.048x
OMV AG ADR 1
F:OMVI
0.036x
Suncorp Group Ltd
AU:SUNPH
-0.042x
Solar Industries India Limited
NSE:SOLARINDS
0.015x
Grupo Carso S.A.B. de C.V
MX:GCARSOA1
-0.002x
Banco Bradesco S.A
F:BREC
-0.111x
Lingyi iTech Guangdong Co
SHE:002600
0.086x
Brookfield Infrastructure Partners L.P
TO:BIP-UN
0.026x

Annual Cash Flow Conversion Efficiency for Viatris Inc (1985–2025)

The table below shows the annual cash flow conversion efficiency of Viatris Inc from 1985 to 2025. For the full company profile with market capitalisation and key ratios, see VTRS market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $14.71 Billion $2.32 Billion 0.157x +27.39%
2024-12-31 $18.64 Billion $2.30 Billion 0.124x -9.66%
2023-12-31 $20.47 Billion $2.80 Billion 0.137x -2.38%
2022-12-31 $21.07 Billion $2.95 Billion 0.140x -4.82%
2021-12-31 $20.49 Billion $3.02 Billion 0.147x +174.34%
2020-12-31 $22.95 Billion $1.23 Billion 0.054x -64.64%
2019-12-31 $11.88 Billion $1.80 Billion 0.152x -21.14%
2018-12-31 $12.17 Billion $2.34 Billion 0.192x +24.04%
2017-12-31 $13.31 Billion $2.06 Billion 0.155x -15.74%
2016-12-31 $11.12 Billion $2.05 Billion 0.184x -10.47%
2015-12-31 $9.77 Billion $2.01 Billion 0.206x -33.61%
2014-12-31 $3.28 Billion $1.01 Billion 0.310x -17.14%
2013-12-31 $2.96 Billion $1.11 Billion 0.374x +32.20%
2012-12-31 $3.36 Billion $949.02 Million 0.283x +37.58%
2011-12-31 $3.50 Billion $720.42 Million 0.206x -20.21%
2010-12-31 $3.62 Billion $931.40 Million 0.258x +33.91%
2009-12-31 $3.15 Billion $605.08 Million 0.192x +39.46%
2008-12-31 $2.79 Billion $384.45 Million 0.138x +182.81%
2007-12-31 $3.44 Billion $167.69 Million 0.049x -78.85%
2006-12-31 $1.69 Billion $390.19 Million 0.231x -56.40%
2005-12-31 $787.65 Million $416.56 Million 0.529x +379.23%
2004-12-31 $1.85 Billion $203.71 Million 0.110x -18.80%
2003-12-31 $1.66 Billion $225.58 Million 0.136x -37.23%
2002-12-31 $1.45 Billion $313.14 Million 0.217x -12.37%
2001-12-31 $1.40 Billion $346.47 Million 0.247x +317.55%
2000-12-31 $1.13 Billion $67.02 Million 0.059x -40.25%
1999-12-31 $1.20 Billion $119.22 Million 0.099x -35.76%
1998-12-31 $1.06 Billion $163.40 Million 0.154x +117.79%
1997-12-31 $744.50 Million $52.70 Million 0.071x +0.42%
1996-12-31 $659.70 Million $46.50 Million 0.070x -42.53%
1995-12-31 $616.40 Million $75.60 Million 0.123x -56.63%
1994-12-31 $482.70 Million $136.50 Million 0.283x +201.85%
1993-12-31 $380.00 Million $35.60 Million 0.094x -59.40%
1992-12-31 $296.00 Million $68.30 Million 0.231x +3.43%
1991-12-31 $203.50 Million $45.40 Million 0.223x -12.98%
1990-12-31 $153.30 Million $39.30 Million 0.256x +71.63%
1989-12-31 $127.20 Million $19.00 Million 0.149x -86.14%
1985-12-31 $47.50 Million $51.20 Million 1.078x --

About Viatris Inc

NASDAQ:VTRS USA Drug Manufacturers - Specialty & Generic
Market Cap
$17.91 Billion
Market Cap Rank
#1431 Global
#567 in USA
Share Price
$15.38
Change (1 day)
+0.07%
52-Week Range
$8.74 - $17.39
All Time High
$47.92
About

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and … Read more